human
papillomaviru
hpv
occur
mani
type
caus
cervic
genit
cancer
vaccin
avail
major
cancercaus
hpv
type
mani
other
cover
prevent
measur
herein
present
bioinformat
studi
design
multival
peptid
vaccin
multipl
hpv
type
altern
strategi
viruslik
particl
vaccin
use
techniqu
ration
design
peptid
vaccin
expect
ensur
stabil
vaccin
mani
cycl
mutat
chang
elicit
immun
respons
negat
autoimmun
possibl
use
capsid
protein
sequenc
identifi
sever
peptid
potenti
vaccin
design
hpv
type
although
concern
epitopebind
affin
peptid
identifi
process
techniqu
indic
possi
biliti
multival
adjuv
peptid
vaccin
wider
rang
hpv
type
tailormad
differ
combin
peptid
address
frequenc
variat
type
differ
popul
group
requir
prophylaxi
lower
cost
use
present
time
certain
type
cancer
liver
cancer
cervic
cancer
hodgkin
lymphoma
other
caus
virus
vaccin
well
establish
vaccin
oper
trigger
immun
respons
individu
shown
circumst
immunocompet
individu
protect
primari
tumor
develop
also
establish
healthi
immun
system
act
tumor
suppressor
case
might
facilit
tumor
progress
nevertheless
given
wide
varieti
viral
cancer
progress
diseas
use
immun
system
prevent
cancer
antivir
vaccin
could
reason
procedur
viral
cancer
caus
human
papillomaviru
hpv
hepat
b
virus
effect
prevent
techniqu
papillomavirus
affect
mammalian
avian
reptilian
host
type
hpv
identifi
larg
varieti
hpv
type
believ
evolv
largescal
migrat
human
popul
appear
follow
major
migrat
pattern
viru
gener
spread
sexual
activ
lie
dormant
year
symptom
develop
major
case
viru
caus
wart
bodi
small
fraction
infect
develop
cancer
estim
peopl
develop
hpv
cancer
everi
year
usa
usual
detect
fairli
late
stage
analysi
cancer
worldwid
reveal
million
case
cancer
attribut
infect
around
due
hpv
incid
ratio
number
develop
develop
countri
wide
varieti
hpv
caus
agent
variou
type
cancer
diseas
type
hpv
affect
genit
area
hpv
type
believ
primari
agent
identifi
respons
cancer
one
studi
conduct
among
larg
sampl
patient
histolog
confirm
squamou
cell
cervic
cancer
determin
hpv
type
classifi
high
risk
three
probabl
high
risk
sever
other
lowrisk
type
hpv
type
also
caus
oropharyng
cancer
hpvposit
oropharyng
cancer
attribut
also
determin
caus
cancer
find
import
sinc
hpvposit
oropharyng
squamou
cell
cancer
opscc
report
doubl
period
wherea
hpvneg
opscc
decreas
overal
oral
oropharyng
cancer
worldwid
hpv
associ
type
hpv
known
caus
variou
ailment
caus
recurr
respiratori
papillomatosi
hpv
type
caus
skin
wart
hpv
found
clinic
normal
skin
moreov
proport
variou
type
hpv
vari
across
countri
contin
thu
affect
outcom
standard
prevent
medic
hpv
dna
viru
genom
length
base
pair
compris
nine
segment
code
eight
protein
one
long
control
region
basic
six
earli
protein
two
late
protein
name
outer
capsid
protein
approxim
ratio
protein
form
pentamer
assembl
virion
shell
individu
protein
held
togeth
disulfid
bond
protein
form
basi
vaccin
papillomavirus
unlik
rna
virus
lack
proofread
mechan
dna
virus
capabl
correct
replic
error
much
stabl
mutat
chang
rna
counterpart
thu
dna
virus
conserv
vaccin
effect
longer
period
direct
linkag
type
hpv
cervic
cancer
led
much
research
prophylact
vaccin
common
hpv
type
caus
agent
cervic
cancer
antivir
vaccin
develop
common
hpv
type
caus
cancer
viz
gardasil
merck
co
inc
protect
highrisk
hpv
type
lowrisk
type
cervarix
gsk
protect
hpv
type
adjuv
recombin
protein
vaccin
found
also
protect
hpv
type
efficaci
vaccin
high
limit
select
hpv
due
type
specif
inhibit
prevent
action
wide
rang
hpvrelat
cancer
two
vaccin
leav
coverag
hpvassoci
cancercaus
type
situat
mitig
extent
launch
gardasil
vaccin
protect
hpv
type
cover
older
quadrival
hpv
vaccin
five
addit
oncogen
type
control
test
determin
noninferior
previou
quadrival
hpv
prevent
infect
gener
antibodi
particular
type
hpv
design
effect
type
hpv
vaccin
belong
class
recombin
viruslik
particl
vlp
vaccin
selfassembl
bionanoparticl
mimic
structur
origin
viru
particl
expos
multipl
epitop
surfac
carri
genet
materi
thu
provid
safer
altern
liveattenu
inactiv
vaccin
first
vlp
vaccin
licens
grant
hepat
b
viru
us
food
drug
administr
vlp
vaccin
two
virus
hpv
hepat
e
secur
licens
fact
last
year
three
vaccin
market
mani
new
reemerg
virus
recogn
indic
difficult
expens
must
develop
vlp
vaccin
although
vlp
vaccin
prove
effect
practic
gener
beyond
reach
patient
develop
countri
also
natur
vlp
vaccin
inhibit
attempt
person
medic
may
requir
certain
popul
group
avail
genom
data
understand
immun
respons
immunogenet
variat
new
develop
bioinformat
comput
applic
system
biolog
approach
fashion
new
direct
vaccin
develop
away
tradit
techniqu
liveattenu
inactiv
viru
recombin
vlp
vaccin
move
away
onesizefitsal
concept
massapplic
vaccin
one
person
vaccin
vaccin
ideal
readili
design
individu
genderspecif
racecommunitypopulationspecif
keep
cost
control
strategi
admittedli
gear
moment
hypervari
virus
human
immunodefici
viru
hiv
human
coronaviru
hcv
influenza
other
group
hpv
belong
principl
certainli
appli
ration
design
vaccin
base
genom
immunogenom
inform
scienc
revers
vaccinolog
yet
evolv
technolog
could
pointer
futur
immedi
level
peptid
vaccin
may
altern
strategi
hpv
vlp
vaccin
could
explor
idea
scan
viral
genom
protein
antigen
elicit
immun
respons
synthes
peptid
vaccin
focus
approach
precis
locat
epitop
region
within
antigen
util
elicit
immun
respons
recent
advanc
technolog
bioinformat
field
enabl
computerbas
approach
purpos
synthet
peptid
vaccin
begin
draw
wide
interest
time
easier
construct
bioinformat
approach
lead
shorter
develop
time
vaccin
tailormad
suit
individu
applic
avoid
autoimmun
threat
overal
cheaper
design
market
interest
note
us
nation
institut
health
project
portal
clinicaltrialsgov
http
clinicaltrialsgov
report
mid
april
project
trial
peptid
vaccin
project
vlp
vaccin
project
synthet
peptid
vaccin
carri
computerbas
studi
identifi
target
region
surfac
protein
influenza
rotaviru
interest
appli
techniqu
hpv
see
whether
feasibl
design
peptid
vaccin
diseas
afflict
mani
peopl
develop
nation
econom
burden
much
acut
develop
nation
also
advantag
peptid
vaccin
theori
multival
vaccin
easili
design
market
afford
price
multival
vlp
vaccin
wide
rang
hpv
type
make
possibl
tailormak
differ
combin
peptid
address
frequenc
variat
type
differ
popul
group
therefor
reach
wider
percentag
affect
peopl
suit
individu
commun
countri
popul
higher
much
less
homogen
western
nation
databas
work
major
compon
capsid
assembl
focu
hpv
vaccin
develop
restrict
approach
consider
protein
postpon
consider
capsid
assembl
compon
protein
futur
work
download
sequenc
capsid
gene
variou
hpv
type
genbank
updat
till
march
tabl
list
number
sequenc
differ
hpv
type
form
dataset
use
purpos
present
exercis
annot
hpv
data
also
avail
special
papillomaviru
epistem
databas
maintain
nation
institut
allerg
infecti
diseas
given
high
incid
papillomaviru
infect
one
could
expect
data
accumul
time
method
analysi
method
analysi
describ
detail
previou
paper
especi
studi
ghosh
et
al
initi
scan
librari
sequenc
design
protein
determin
segment
unchang
least
chang
among
variou
strain
coupl
averag
solvent
access
asa
profil
sequenc
select
segment
conserv
highest
solvent
access
profil
determin
epitop
region
within
segment
accept
bind
affin
human
leukocyt
antigen
final
select
peptid
pose
autoimmun
threat
process
crystal
structur
surfac
protein
also
util
ensur
select
peptid
region
cover
solvent
access
due
neighbor
protein
togeth
constitut
quaternari
structur
option
step
process
may
start
observ
graphic
represent
dnarna
sequenc
cartesian
coordin
system
determin
similar
select
gene
sequenc
conserv
segment
within
select
sequenc
system
sequenc
repres
point
nucleotid
success
plot
seri
step
one
step
neg
xdirect
adenin
posit
ydirect
cytosin
posit
xdirect
guanin
neg
ydirect
thymin
gener
plot
sequenc
reflect
base
distribut
sequenc
quantit
measur
take
weight
center
mass
x
point
distanc
centr
mass
cm
center
graph
radiu
g
r
consid
characterist
sequenc
protein
sequenc
concept
extend
rectangular
coordin
system
dimens
amino
acid
aa
associ
particular
direct
protein
sequenc
plot
take
success
step
direct
dictat
aa
sequenc
plot
abstract
space
defin
weight
center
mass
protein
graph
radiu
p
r
g
r
special
properti
g
r
p
r
case
two
sequenc
result
graph
radiu
albeit
adjust
p
r
specifi
studi
ghosh
et
al
sequenc
found
ident
properti
use
sever
instanc
previous
use
current
work
determin
protein
sequenc
segment
varieti
determin
number
instanc
p
r
ident
see
detail
determin
target
peptid
consid
elicit
immun
respons
step
process
briefli
global
view
gene
sequenc
determin
similar
dissimilar
sequenc
graphic
represent
plot
gener
gene
sequenc
differ
hpv
type
visual
inspect
determin
appear
similar
club
togeth
analysi
identif
protein
conserv
segment
virus
gener
high
mutat
rate
rna
virus
dna
virus
mutat
rate
dsdna
hpv
low
nevertheless
mutat
occur
lead
variou
strain
popul
papillomaviru
databas
higher
differ
type
smaller
differ
within
type
phylogenet
tree
protein
sequenc
primari
hpv
type
interest
work
five
strain
type
bring
featur
explicitli
fig
given
strict
type
specif
neutral
antibodi
mutat
aa
composit
delet
insert
may
take
place
impli
specif
case
neutral
antibodi
rais
one
strain
may
viabl
anoth
strain
although
success
current
hpv
vaccin
show
may
happen
seldom
interest
identifi
peptid
segment
chang
least
strain
reduc
possibl
instanc
examin
whether
one
segment
could
form
basi
peptid
vaccin
methodolog
follow
purpos
map
protein
sequenc
use
window
aa
slide
increment
one
aa
time
ie
comput
p
r
segment
aa
no
say
chosen
window
size
aa
anoth
p
r
stretch
aa
no
end
aa
sequenc
reach
stage
peptid
graph
radiu
p
r
comput
store
see
ref
detail
repeat
protein
sequenc
select
group
sequenc
entir
lot
scan
map
aa
posit
determin
number
differ
p
r
valu
among
sequenc
sinc
p
r
valu
repres
particular
peptid
sequenc
number
valu
p
r
aa
posit
map
protein
varieti
profil
aa
cover
slide
window
minima
profil
indic
region
varieti
infer
chang
aa
rel
least
indic
conserv
region
size
window
cover
number
aa
need
care
consider
previou
analysi
neuraminidas
protein
consid
peptid
length
aa
rotaviru
mutat
chang
occur
frequent
consid
prudent
consid
window
size
aa
residu
peptid
found
potent
antigen
compar
smaller
peptid
use
size
analysi
influenza
hemagglutinin
may
note
peptid
length
aa
use
scan
bcell
epitop
peptid
residu
may
contain
overlap
linear
bcell
epitop
cytotox
tcell
epitop
limit
length
residu
wherea
helper
tcell
longer
peptid
length
use
consid
issu
fact
hpv
virus
dsdna
type
therefor
compar
stabl
fix
window
length
exercis
aa
solvent
access
profil
protein
sequenc
next
map
solvent
access
subject
asa
server
itass
http
zhanglabccmbmedumich
eduitass
sabl
http
sablecchmcorg
suitabl
webbas
server
take
averag
aa
solvent
access
index
aa
posit
averag
sever
sequenc
hpv
type
map
reveal
solvent
access
region
maxima
graph
first
cut
peptid
segment
map
graph
name
peptid
variabl
profil
solvent
access
profil
togeth
scan
region
protein
variabl
least
solvent
access
among
highest
first
list
conserv
solvent
access
segment
protein
confirm
structur
second
cut
choic
confirm
region
identifi
previou
step
inde
surfac
situat
examin
identifi
region
protein
structur
eg
shown
softwar
avail
nih
websit
mark
identifi
segment
one
protein
structur
reveal
much
segment
lie
surfac
composit
structur
protein
protein
avail
finetun
select
process
identifi
segment
realli
lie
expos
surfac
capsid
protein
get
cover
neighbor
protein
virion
determin
epitop
segment
next
consid
segment
secondstag
choic
contain
epitop
region
elicit
necessari
immun
respons
use
two
epitopepredict
tool
viz
immun
epitop
databas
iedb
analysi
resourc
server
abcpr
server
mention
earlier
given
good
result
tool
indic
bind
affin
tcell
epitop
bcell
epitop
accuraci
major
histocompat
complex
mhc
also
discontinu
epitop
ellipro
autoimmun
test
final
test
peptid
remain
third
stage
ensur
possess
autoimmun
threat
uniqu
peptid
peptid
segment
subject
proteinprotein
blast
ensur
select
peptid
homolog
human
protein
caus
autoimmun
threat
segment
becom
recommend
peptid
vaccin
subject
final
verif
wet
laboratori
autoimmun
threat
potenti
hazard
explor
one
earlier
report
initi
attempt
determin
common
motif
conserv
peptid
sequenc
gene
hpv
type
avail
databas
given
tabl
met
littl
success
signal
low
variabl
observ
heavili
influenc
preponder
data
databas
fact
detail
inspect
peptid
stretch
correspond
signal
region
show
littl
homolog
sequenc
observ
nucleotid
plot
also
fig
show
close
similar
two
group
distinctli
differ
plot
indic
signific
differ
base
distribut
previou
analys
vaccin
target
consid
larg
number
sequenc
one
primari
type
viz
neuraminidas
hemagglutinin
influenza
genom
protein
rotaviru
present
instanc
consid
differ
type
hpv
similar
within
sequenc
type
greater
similar
sequenc
differ
type
note
remark
chen
et
al
differ
gene
clone
sequenc
character
type
becom
new
type
claim
establish
els
strain
type
group
phylogenet
tree
fig
show
explicitli
strain
type
belong
individu
group
differ
type
form
separ
clade
belong
one
clade
anoth
graph
fig
also
show
glanc
close
similar
also
indic
two
group
differ
thu
earlier
experi
could
repeat
consid
intertyp
differ
howev
larg
differ
within
type
eg
hpv
type
iran
african
type
variant
quit
differ
dsdna
type
virus
expect
region
ie
within
popul
group
stabl
consid
preponder
data
former
varieti
relat
sequenc
use
analys
analys
three
highrisk
type
done
togeth
use
p
r
techniqu
mention
materi
method
section
aa
window
p
r
valu
aa
posit
scan
determin
number
differ
valu
number
smooth
rang
posit
run
averag
comput
complet
sequenc
next
asa
profil
determin
sever
sampl
select
hpv
type
use
sabl
server
found
quit
reliabl
take
averag
solvent
access
number
determin
residuewis
sequenc
sabl
take
run
averag
aa
get
smooth
solvent
access
profil
whose
peak
indic
highest
solvent
access
around
residu
posit
logic
region
lowest
varieti
number
aa
stretch
match
highest
valu
asa
profil
repres
potenti
best
situat
highli
conserv
surfac
access
peptid
segment
protein
sequenc
figur
show
plot
two
profil
highrisk
type
five
region
identifi
mark
short
horizont
line
analysi
identifi
term
aa
region
determin
varieti
vs
asa
profil
scan
aa
sequenc
region
three
hpv
type
found
close
similar
peptid
stretch
extend
fact
sever
aa
beyond
aa
window
aa
varieti
vs
asa
profil
curv
also
drawn
similarli
appropri
peptid
segment
identifi
tabl
list
peptid
identifi
segment
five
highrisk
hpv
type
also
lowrisk
determin
similar
method
sinc
hpv
virion
capsom
compos
five
protein
one
possibl
surfac
access
antigen
one
protein
may
get
cover
fold
neighbor
protein
step
three
search
vaccin
target
region
verifi
surfac
access
identifi
region
protein
crystal
structur
exercis
use
avail
protein
data
bank
individu
check
region
spacefil
model
sinc
structur
avail
detail
comparison
omit
figur
respect
give
snapshot
identifi
peptid
highlight
yellow
one
protein
pentamer
structur
capsid
assembl
case
region
surfac
access
solitari
hpv
protein
peptid
stretch
almost
entir
cover
adjac
protein
therefor
reject
vaccin
target
candid
region
found
entir
viabl
case
region
origin
aa
stretch
found
surfac
situat
aa
found
cover
neighbor
residu
ie
even
extend
segment
belong
group
conserv
residu
part
beyond
origin
stretch
viabl
candid
vaccin
target
interestingli
two
region
two
side
protein
surfac
access
segment
avail
consider
potenti
vaccin
target
mark
red
tabl
region
list
tabl
could
test
similar
manner
due
nonavail
stretch
protein
crystal
note
list
regionwis
show
peptid
segment
similar
segment
mark
red
cover
neighbor
proteinssequ
overlap
sinc
crystal
structur
avail
overlap
region
could
ascertain
expect
similar
similar
consider
appli
compar
next
stage
determin
identifi
region
epitop
potenti
enabl
immun
respons
use
iedb
server
test
tcell
mhc
ii
epitop
region
use
two
allel
name
tabl
show
region
identifi
pass
mhc
ii
test
although
instanc
one
allel
gave
result
outsid
permiss
rang
gener
immun
respons
howev
none
region
three
hpv
type
fail
allel
likewis
test
bcell
humor
respons
abcpr
server
known
predict
epitop
region
bcell
respons
accuraci
seen
result
extract
tabl
find
instanc
region
pass
test
high
accept
rank
except
region
whose
score
outsid
critic
rang
linear
conform
epitop
found
protein
surfac
well
establish
neutral
antibodi
product
conform
epitop
ludmer
et
al
show
distinct
surfaceexpos
linear
epitop
overlap
neighbor
conform
epitop
vlp
neutral
epitop
also
bind
linear
epitop
combita
et
al
experi
mice
model
confirm
exist
linear
epitop
induc
crossneutr
also
infer
crossneutr
exceed
effect
domin
conform
epitop
typespecif
crossreact
linear
epitop
determin
protein
surfac
also
present
purpos
restrict
analys
protein
epitop
test
identifi
linear
epitop
sinc
papillomaviru
protein
mostli
conform
epitop
test
discontinu
epitop
aa
sequenc
also
ellipro
avail
iedb
web
server
found
hpv
type
investig
almost
identifi
peptid
overlap
conform
epitop
figur
display
spacefil
render
protein
pentamer
structur
conserv
surfaceexpos
segment
identifi
comparison
protein
variabl
asa
profil
analysi
given
tabl
peptid
overlap
mark
tabl
tabl
also
show
percentil
rank
bind
affin
hla
mhc
class
predict
iedb
server
number
peptid
region
show
low
rank
indic
high
bind
affin
remain
test
envisag
autoimmun
possibl
proteinprotein
blast
analysi
use
nonredund
protein
sequenc
genbank
pdb
swissprot
etc
result
found
match
super
papillomaviru
famili
match
nonhpv
protein
final
list
identifi
peptid
stretch
met
criteria
could
serv
potenti
peptid
vaccin
target
given
tabl
end
four
possibl
surfac
access
highli
conserv
peptid
region
common
sever
type
show
less
bind
affin
tcell
bcell
activ
region
appear
pure
linear
epitop
overlap
discontinu
epitop
larg
everi
peptid
segment
identifi
exercis
show
prospect
elicit
immun
respons
instanc
crossneutr
type
seem
possibl
would
requir
howev
wet
laboratori
experi
adjuv
combin
valid
model
altern
strategi
improv
expand
upon
possibl
multival
peptid
vaccin
approach
prevent
hpvinduc
cancer
cervic
genit
cancer
suffer
caus
larg
varieti
viru
prepar
strongli
advoc
note
repres
accept
bind
affin
discontinu
epitop
could
determin
due
mismatch
homolog
